Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative CEUS for Femoral Head Perfusion in Infants With DDH
NCT03107520Phase 1Recruiting
- Sponsor
- Children's Hospital of Philadelphia
- Start
- May 2017
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sulfur hexafluoride in developmental dysplasia of the hip (DDH), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Visualization of epiphyseal vascularity in the femoral head at 1 day. Started May 2017; status: recruiting.
02
Drugs
sulfur hexafluoride
03
Conditions
developmental dysplasia of the hip (DDH)
Beyond the preview
Go deeper on NCT03107520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107520.